Key points are not available for this paper at this time.
When managing an older patient with untreated acute myeloid leukemia (AML), my primary goal is to determine whether standard treatment, investigational treatment, or palliative care is most appropriate. “Standard therapy” includes remission induction regimens, commonly referred to as “3 +
Elihu H. Estey (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: